Adial pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Adial pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 1.745 million compared to usd 3.816 million a year ago. net loss was usd 1.715 million compared to usd 8.190 million a year ago. basic loss per share was usd 0.17 compared to usd 1.48 a year ago. for the nine months, operating loss was usd 6.154 million compared to usd 5.897 million a year ago. net loss was usd 6.532 million compared to usd 10.362 million a year ago. basic loss per share was usd 0.68 compared to usd 2.51 a year ago.
ADIL Ratings Summary
ADIL Quant Ranking